Multicenter, Dose-Finding Safety and Activity Study of AMD11070 in HIV-Infected Patients Carrying X4-Tropic Virus.

Trial Profile

Multicenter, Dose-Finding Safety and Activity Study of AMD11070 in HIV-Infected Patients Carrying X4-Tropic Virus.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs AMD 070 (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms XACT
  • Sponsors AnorMED; Genzyme Corporation
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 Sep 2010 Actual end date (October 2005) added as reported by ClinicalTrials.gov.
    • 08 Sep 2010 Status changed from suspended to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top